Clinical Trial Update: Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ALC for breast cancer with fatigue was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ALC

Snippet

Sponsor: Sigma-Tau Research, Inc. | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED